Kabir, Mohammed Anowrul,Naderer, Odin Johann,Grossi, Irma Marisa
申请号：
AU2017290703
公开号：
AU2017290703A1
申请日:
2017.06.28
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Disclosed are formulations comprising brincidofovir. The formulations can be intravenous formulations. The formulations can be used in cases where a subject experiences gastrointestinal issues in response to oral administration of brincidofovir. The formulations can also be used in cases where oral administration of drug is not possible due to underlying conditions or concern around inadequate oral absorption.
